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Abstract
Insight into the normal function of PrP
C, and how it can be subverted to produce neurotoxic effects, is provided by PrP
molecules carrying deletions encompassing the conserved central region. The most neurotoxic of these mutants, D105–125
(called DCR), produces a spontaneous neurodegenerative illness when expressed in transgenic mice, and this phenotype
can be dose-dependently suppressed by co-expression of wild-type PrP. Whether the toxic activity of DCR PrP and the
protective activity or wild-type PrP are cell-autonomous, or can be exerted on neighboring cells, is unknown. To investigate
this question, we have utilized co-cultures of differentiated neural stem cells derived from mice expressing DCR or wild-type
PrP. Cells from the two kinds of mice, which are marked by the presence or absence of GFP, are differentiated together to
yield neurons, astrocytes, and oligodendrocytes. As a surrogate read-out of DCR PrP toxicity, we assayed sensitivity of the
cells to the cationic antibiotic, Zeocin. In a previous study, we reported that cells expressing DCR PrP are hypersensitive to
the toxic effects of several cationic antibiotics, an effect that is suppressed by co-expression of wild type PrP, similar to the
rescue of the neurodegenerative phenotype observed in transgenic mice. Using this system, we find that while DCR-
dependent toxicity is cell-autonomous, the rescuing activity of wild-type PrP can be exerted in trans from nearby cells. These
results provide important insights into how DCR PrP subverts a normal physiological function of PrP
C, and the cellular
mechanisms underlying the rescuing process.
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Introduction
Prion diseases are fatal neurodegenerative disorders of humans
and animals that are characterized by dementia, motor dysfunc-
tion, cerebral amyloidosis, and spongiform degeneration of the
brain [1]. The diseases manifest themselves in genetic, infectious,
and sporadic forms. All of these forms are caused by conforma-
tional conversion of PrP
C, a normal, cell surface glycoprotein into
a b-sheet-rich, aggregated isoform termed PrP
Sc. A great deal of
evidence suggests that PrP
Sc is an infectious agent that propagates
itself by seeding misfolding of PrP
C substrate molecules in a
template-directed fashion [2,3].
Although it is commonly accepted that PrP
Sc is a hallmark of
prion diseases, emerging evidence suggests that its neurotoxicity
relies on the presence of functional PrP
C molecules at the cell
surface [4]. This conclusion is supported by the observation that
the depletion of neuronal PrP
C in mice with an established prion
infection reversed both neuronal loss and the progression of
clinical signs, despite the continuous production of PrP
Sc by
surrounding glial cells [5,6]. This and other lines of evidence have
sparked renewed efforts to understand the normal function of
PrP
C and how it may be hijacked to generate toxicity [7,8].
Multiple functions have been attributed to PrP
C in the last decade,
including roles in cell adhesion, metal ion homeostasis, neuropro-
tection from various cellular stresses, and transduction of toxic
signals delivered by several misfolded proteins [9,10]. However,
the physiological role of PrP
C remains unclear, and thus far no
robust assays have been developed for testing its function in vitro.
A possible clue into the physiological activity of PrP
C is provided
by transgenic (Tg) mice expressing PrP forms carrying deletions
within the central region. One of these lines, expressing a mutant
PrP molecule deleted for residues 105–125 (referred to as DCR),
displays a severe neurodegenerative phenotype characterized by
progressive loss of cerebellar granular neurons (CGNs), astro-
gliosis, and white matter vacuolization [11]. Surprisingly, DCR
PrP, like its wild-type (WT) counterpart, is monomeric and
localized mainly in lipid rafts at the cell surface, suggesting that the
deletion of residues 105–125 alters a normal, physiological
function of PrP, rather than causing the protein to adopt a
PrP
Sc-like conformation [12]. In addition, both neurodegeneration
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expression of WT PrP, suggesting that WT and mutant molecules
could be acting through the same molecular pathway, or
competing for a common ligand [11]. In either case, understand-
ing how DCR PrP exerts its toxic effect will likely provide
important clues to the physiological activity of PrP
C.
In previous work, we found that expression of DCR PrP induced
a strong ion channel activity in transfected cells that could be
detected by patch-clamping techniques [13,14]. In addition, this
mutant rendered a variety of cell lines, including HEK293, N2a,
Sf9 and differentiated mouse neural stem cells (NSCs), hypersen-
sitive to several cationic antibiotics, including G418, Zeocin and
hygromycin [15]. This phenotype provided the basis for a novel
cell culture assay to study the activity of PrP mutants, referred to as
the Drug-Based Cell Assay (DBCA) [16]. Analogous to its ability to
reverse the neurodegenerative phenotype of Tg(DCR) mice, WT
PrP suppressed DCR PrP-induced drug hypersensitivity and ion
channel activity, suggesting that similar cellular mechanisms are
operative in each of these settings. Therefore, the DBCA provides
an unprecedented opportunity to dissect PrP
C function at a
cellular level.
Previous experiments establish that DCR PrP is toxic to
neurons, and this effect is suppressed by the co-expression of
WT PrP. However, it is not known whether the toxic activity of
DCR PrP and the protective activity of WT PrP are cell-
autonomous, or can be exerted on neighboring cells. Since PrP is a
cell-surface protein, it could potentially interact via both kinds of
mechanisms. Here, we established a novel NSC-based version of
the DBCA to define whether or not the antibiotic-hypersensitizing
effect of DCR PrP and the rescuing activity of WT PrP are cell-
autonomous. We describe the intriguing observation that DCR
PrP induces antibiotic hypersensitivity in a cell-autonomous
fashion, and that this effect can be rescued by WT PrP expressed
on neighboring cells. These results provide new insights into the
cellular mechanisms underlying the neurotoxic and neuroprotec-
tive functions of PrP
C.
Results
Characterization of mouse NSC cultures
In a preliminary set of experiments, we sought to characterize
the properties of NSCs derived from several mouse lines, including
non-transgenic Prn-p
+/+ (WT), Prn-p
2/2 (KO), Tga20
+/+/Prn-p
0/0
(Tga) and Tg(DCR)/Prn-p
0/0(DCR) mice. In the presence of
epidermal growth factor (EGF), NSCs from all mouse lines formed
spheroid bodies (or neurospheres), measuring 50–200 mmi n
diameter, which could replicate in culture for multiple passages
(Figure 1A and data not shown). Differentiation was achieved by
Figure 1. NSCs propagate as spheroid bodies and form a monolayer upon differentiation. (A) NSCs cultured in complete media
(containing EGF) grow as 100–200 mm neurospheres, capable of self-renewal. (B) Phase-contrast, time-lapse microscopy shows that NSCs cultured in
the absence of EGF, with the addition of serum and retinoic acid, form a monolayer within 72 h. Representative pictures from WT and DCR NSCs are
shown. Scale bars=100 mm.
doi:10.1371/journal.pone.0033472.g001
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retinoic acid (RA), and plating the neurospheres on an adhesive
substrate (poly-D-lysine/laminin). The morphological changes
accompanying the differentiation of neurospheres were monitored
by time-lapse microscopy for 3 days (Figure 1B). We observed that
newly differentiated NSCs migrated hundreds of micrometers
away from the original neurosphere, giving rise to a monolayer of
cells. No obvious difference was seen between NSCs from different
mouse lines.
In order to confirm differentiation of NSCs in culture, we
measured expression of the stem cell marker, nestin, an
intermediate filament protein expressed in the CNS during early
stages of development [17,18]. As expected, we observed
progressive down-regulation of nestin during differentiation of
DCR NSCs, both by immunofluorescence (Figure 2A) and
Western blotting (Figure 2B). Nestin expression became almost
undetectable after 10 days of differentiation, coincident with a
slight increase in the neurofilament protein MAP-2 (Figure 2B).
No differences were found among the different NSC lines (not
shown).
Upon differentiation, stem cells are expected to give rise to
mixed cultures of mature astrocytes, oligodendrocytes and neurons
[19]. In order to check for the presence of these cell types, we
stained differentiated NSCs with antibodies against the glial
fibrillary acidic protein (GFAP), a marker of astrocytes, and the
myelin basic protein (MBP), a marker of oligodendrocytes
(Figure 3A–B). We estimated that astrocytes represented ,70%
of the cells in differentiated WT and DCR NSC cultures, while
oligodendrocytes were approximately 5%. Neurons were detected
by double staining with the dendritic marker MAP-2 and the
axonal marker SMI-31 (Figure 3C–D). Approximately 25% of
cells were positive for both markers. Importantly, we observed a
lack of co-localization between the axonal marker SMI-31 and the
dendritic marker MAP-2, which suggests that NSC-derived
neurons are correctly polarized (Figure 3 C–D). NSCs from
different mouse lines did not differ in their ability to differentiate.
To verify that the level of PrP expression in differentiated NSC
lines was similar to that found in the brain of the corresponding
mouse line, protein extracts from undifferentiated NSCs and
mouse brains were incubated with PNGase F to remove N-linked
glycans, and were analyzed by Western blotting. Similar to the
case in brain tissue (Figure 4A, lanes 1–3, lower panel), there was
much higher PrP expression in NSCs derived from Tga mice as
compared to those from WT mice, with DCR NSCs displaying
Figure 2. Nestin expression is decreased in differentiated NSCs. (A) NSCs grown in complete media have high levels of nestin expression
(green), which decreased after 10 days in differentiation media. DAPI staining is shown in blue. Representative pictures from DCR NSCs are shown.
Scale bar=50 mm. (B) NSCs harvested after differentiation for the indicated number of days were immunoblotted with anti-nestin and anti-MAP-2
antibodies. After 10 days of differentiation, nestin is almost undetectable, coincident with a slight increase in MAP-2 expression. Molecular size
markers are given in kDa.
doi:10.1371/journal.pone.0033472.g002
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panel). As expected, KO NSCs showed no PrP expression
(Figure 4A, lane 4). No differences were seen between PrP
expression levels in NSCs and mouse brains (Figure 4A, compare
upper and lower panels). To study the expression of PrP upon
differentiation, NSCs were collected at different time points and
Figure 3. Differentiated NSCs express markers for astrocytes, oligodendrocytes, and neurons. (A–B) Differentiation of NSCs gives rise to
cells expressing the astrocytic marker GFAP (red) and the oligodendrocyte marker MBP (green). (C–D) Differentiated NSC cultures also include
neurons expressing dendritic (MAP-2, red) and axonal (SMI-31, green) markers. The absence of co-localization of the two neuronal markers indicates
polarization of neurons after differentiation. For both (A) and (B), DAPI staining is shown in blue. Representative pictures from WT and DCR NSCs are
shown. Scale bars=20 mm.
doi:10.1371/journal.pone.0033472.g003
Figure 4. PrP expression in NSCs correlates with levels in brain and increases during differentiation. (A) Equivalent amounts of total
protein extracts from brain homogenates or undifferentiated NSCs of the indicated genotypes were treated with PNGase F, and PrP was detected by
Western blotting using 6D11 antibody. (B) NSCs of the indicated genotypes were collected at the indicated time points during the course of
differentiation, and PrP was detected by Western blotting after treatment with PNGase. The amount of PrP increased slightly by day 10.
doi:10.1371/journal.pone.0033472.g004
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observed a small increase in PrP expression over the 10 days of
differentiation in all of the NSC lines (Figure 4B).
Finally, in order to visualize PrP expression in fully differenti-
ated neuronal and non-neuronal NSCs, we co-stained cells with
anti-PrP (6D11) and anti-MAP-2 antibodies. PrP was detected on
the cell membrane in both neuronal (MAP-2 positive) and non-
neuronal (MAP-2 negative) cells (Figure 5, A–C), while it was not
detected in KO cells (Figure 5D).
These results indicate that viable NSCs can be recovered from
WT, Tga, KO and DCR mice. No difference in self-renewal or
time course of differentiation was detected among the different
NSC lines. Moreover, these cells correctly expressed PrP at the cell
surface, with relative PrP levels identical to those observed in brain
tissue from the corresponding mouse lines.
DCR PrP-related hypersensitivity to Zeocin is cell
autonomous
As described in a previous report, despite the potent
neurotoxicity of DCR PrP in vivo, only a small percentage of
dying cells (as assayed by TUNEL staining) can be detected in
differentiated DCR NSCs, compared to controls [15]. However,
the percentage of TUNEL-positive DCR NSCs (but not WT
NSCs) dramatically increases after treatment with Zeocin, G418
or hygromicin [15]. Taking advantage of this cellular phenotype,
we designed an experiment to characterize whether the drug-
hypersensitizing effect of DCR is cell-autonomous (in cis) or can
also be exerted in trans on neighboring cells.
KO, Tga and DCR mice were bred with PrP-ablated Tg mice
expressing a cytoplasmic form of the green fluorescent protein
(GFP) under the control of the actin B promoter [referred to as
Tg(ACTB-EGFP/Prn-p
0/0) mice]. Mice derived from these crosses
were used to prepare either GFP-positive (green) or GFP-negative
(black) NSCs of each PrP genotype. To verify that we were able to
discriminate between green and black NSCs in mixed cultures,
black and green DCR NSCs were cultured together and imaged by
phase contrast (Figure 6, panels A and C) or fluorescence (panels B
and D) microscopy. The analysis was performed either before
(Figure 6, panels A and B) or after (panles C and D) differentiation.
We found that black and green cells could be easily identified both
before and after differentiation. Time-lapse microscopy of differen-
tiating black and green NSCs, imaged by phase contrast (Figure 7A)
and GFP fluorescence (Figure 7B), revealed that black and green
NSCs start to disperse into each other within three days of
differentiation (Figure 7C). These results demonstrate that pre-
mixed black and green NSCs form a uniform cell layer during
differentiation, and that individual black and green cells can be
identified by the presence or absence of the GFP fluorescence.
In order to test whether the presence of GFP or the mixing
procedure affected the distribution of cell types, we stained co-
cultures of green WT and black KO, or green DCR and black KO
NSCs with markers for astrocytes (GFAP), neurons (MAP-2), or
oligodendrocytes (MBP) (data not shown). We confirmed that the
relative percentage of the different cell types was overall
unchanged in the different co-coltures (astrocytes were 70%,
neurons ,25% and oligodendrocytes ,5%). We also detected PrP
by immunostaining in the same mixed cultures and found that the
expression of PrP, either WT or DCR, was unchanged compared
to unmixed cultures (data not shown). These results confirmed that
neither the presence of GFP, nor the co-culturing method, altered
the differentiation of NSCs or the expression of PrP.
To test whether DCR PrP exerts its effect in cis or in trans,w e
assayed hypersensitivity to Zeocin of mixed cultures of green KO
and black DCR NSCs, or black KO and green DCR NSCs. If
DCR PrP acts in trans, then both KO and DCR NSCs should
become hypersensitive to Zeocin. In contrast, if the toxic activity of
this mutant PrP is cell-autonomous, only DCR-expressing NSCs
should be hypersensitive to Zeocin. Black and green neurospheres
were mixed and differentiated for 10 days, then treated with
Zeocin to unmask the DCR-dependent hypersensitivity to this
Figure 5. PrP is expressed on the plasma membrane in differentiated NSCs. Surface staining of differentiated NSCs shows PrP (green)
expression on the surface of both neuronal (MAP-2 positive cells [red]) and non-neuronal (MAP-2 negative) cells from Tga (A), WT (B), and DCR(C), but
not KO (D) cells. PrP was detected with 6D11 antibody.
doi:10.1371/journal.pone.0033472.g005
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TUNEL to identify apoptotic cells, and reacted with DAPI to
visualize the nuclei of all cells. TUNEL-positive cells were
identified as belonging to either the green or black cell population,
and expressed as percentage of total cells identified by DAPI
staining.
Figure 6. Detection of GFP-positive NSCs. (A) Phase contrast image of undifferentiated neurospheres of mixed GFP-positive and GFP-negative
origin. (B) Green fluorescent signal from the same neurospheres shown in (A). Note the presence of both GFP-positive (red arrows) and GFP-
negative(yellow arrows) NSCs. (C) Phase image of the mixed culture after differentiation. (D) Green fluorescent signal from the NSCs shown in (C)
demonstrates that differentiated GFP-positive and GFP-negative NSCs have mixed during migration. Scale bar=100 mm.
doi:10.1371/journal.pone.0033472.g006
Figure 7. Time-lapse analysis of NSCs mixing upon differentiation. The intermixing of GFP-positive and GFP-negative NSCs during
differentiation was monitored by time-lapse microscopy. Images of the differentiating cells were taken by phase contrast microscopy (A), or by
fluorescence microscopy to detect the green fluorescent signal (B). A merge of the two series of images (C) illustrates how differentiated GFP-positive
and GFP-negative migrate and mix during the first 72 h of differentiation. Representative pictures from DCR NSCs are shown. Scale bars=100 mm.
doi:10.1371/journal.pone.0033472.g007
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black DCR NSCs (Figure 8B). As expected, we found that only a
small percentage (,3%) of KO cells, either green or black, were
TUNEL-positive after exposure to Zeocin, while a much higher
percentage (,20%) of both green and black DCR cells showed
sensitivity to this antibiotic (Figure 8E). These results confirmed that
the presence of GFP does not interfere with the DCR-dependent
hypersensitivity to Zeocin. Next, we mixed black KO and green
DCR cells. This time we found that TUNEL-positive nuclei
belonged almost entirely to green DCR cells (Figure8C and E). This
result was also confirmed in the complementary experiment, in
which green KOcellswere mixedwith blackDCRcells.Inthis case,
TUNEL-positive nuclei were detected almost entirely in black DCR
cellsandnotinthegreenKOcells(Figure 8DandE).Weconcluded
that DCR PrP does not induce hypersensitivity to Zeocin in
neighboring KO cells. Therefore, this PrP mutant exerts its toxic
activity in a cell-autonomous fashion (in cis).
WT PrP rescuing activity can be exerted in trans
We previously demonstrated that the DCR-dependent hyper-
sensitivity to Zeocin could be rescued by co-expression of WT PrP
in the same cells (in cis) [15]. By using the experimental paradigm
described above, we tested whether such rescuing activity of WT
PrP could also be exerted by expression of WT PrP on
neighboring cells (in trans). Cultures of green or black Tga and
DCR NSCs were mixed, differentiated and treated with Zeocin. If
WT PrP exerts its rescue effect in trans, then both Tga and DCR
NSCs should be resistant to Zeocin. Conversely, if the rescuing
activity is cell-autonomous, then only Tga NSCs should be
protected.
First we mixed green and black Tga NSCs (Figure 9). As
expected, we found that only a small percentage (,3%) of these
cells, either green or black, were TUNEL-positive after exposure
to Zeocin.
Then, we mixed black Tga and green DCR neurospheres, and
measured the percentage of TUNEL-positive cells after treatment
with Zeocin. As positive control for the rescue, we treated with
Zeocin black NSCs derived from doubly Tg mice co-expressing
DCR PrP and the Tga transgene (Tga/DCR NSCs). As expected,
we found only few (.5%) TUNEL-positive nuclei in both black
Tga and Tga/DCR NSCs. Surprisingly, we detected a significantly
reduced number of TUNEL-positive nuclei in green DCR NSCs
co-cultured with black Tga NSCs, as compared to control green
DCR cells cultured alone. This observation was confirmed by
mixing green Tga NSCs with black DCR NSCs. Also in this case,
we detected a much lower percentage of TUNEL-positive nuclei
in black DCR NSCs co-cultured with green Tga NSCs, as
compared to black DCR cultured alone. These results indicated
that WT PrP can exert its rescuing effect in trans. Interestingly, we
found that the number of TUNEL-positive nuclei in DCR NSCs
co-cultured with Tga20 NSCs was still significantly higher than in
Tga/DCR NSCs co-expressing the WT and mutant proteins in the
same cells (Figure 9). This result suggests that the trans-rescuing
effect of Tga NSCs toward DCR cells was not as efficient as the cis-
rescuing effect.
Cis-toxicity of DCR and trans-rescuing activity of WT PrP
are both detectable in HEK293 cells
We sought to test whether our observations in differentiated
NSCs also applied to non-CNS derived cell types. We turned to
HEK293 cells, which we have used extensively as a cell model for
the DBCA [15,16]. In order to mimic the approach described for
NSCs, we transduced HEK293 cells stably expressing DCR PrP
with a recombinant lentivirus encoding for cytoplasmic GFP. A
Figure 8. DCR PrP-dependent hypersensitivity to drugs is cell-autonomous. NSCs from E13.5 mouse embryos were cultured as
neurospheres and differentiated for 10 days in presence of retinoic acid. Differentiated NSCs were treated for 24 hrs with Zeocin (500 mg/ml), then
stained by TUNEL (red) to reveal fragmented DNA (indicated by yellow arrows) and with DAPI (blue) to stain nuclei. GFP-negative or GFP-positive
NSCs from of KO or DCR mice were mixed as follow: (A) GFP-negative and GFP-positive KO cells; (B) GFP-negative and GFP-positive DCR cells; (C)
GFP-negative KO cells mixed with GFP-positive DCR cells; (D) GFP-positive KO cells mixed with GFP-negative DCR cells. (E) The bar graph shows the
number of TUNEL-positive cells, expressed as a percentage of the number of DAPI-stained cells, as determined in 5–7 fields for each sample group.
Bars show means 6 SEM (n=5 independent experiments). The number of TUNEL-positive DCR cells, either GFP-positive or GFP-negative, was
significantly higher than the number of TUNEL-positive KO cells (*** p,0.001) when DCR and WT cells were cultured together (groups C and D).
doi:10.1371/journal.pone.0033472.g008
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GFP was then obtained by fluorescence activated cell sorting
(FACS) (data not shown). Importantly, these cells maintained the
same DCR PrP expression level as the original clone (Figure 10A).
In order to test the cis-hypersensitizing effect of DCR PrP and
the trans-rescuing activity of WT PrP, green DCR cells were
mixed in a 1:1 ratio with black (non-transduced) cells expressing
either empty vector, WT or DCR PrP, and then treated with
Zeocin for 48 h (Figure 10B). As a read-out, we counted the total
amount of cells, either green or black (Figure 10C). As expected,
when green and black DCR cells were mixed, the treatment with
Zeocin diminished the number of both green and black cells to
about 30% compared to untreated cells. In contrast, when green
DCR cells were mixed with vector-transfected cells, Zeocin
diminished only the number of green DCR cells, while the
number of vector cells was unaffected. This result confirmed that
DCR-dependent hypersensitivity to Zeocin is cell autonomous.
Morevoer, we detected a significant rescue of green DCR cells
when these were co-cultured with WT-expressing cells. This
confirmed the ability of WT PrP to rescue DCR-dependent
hypersensitivity in trans.
Collectively, these results indicate that the cis-toxicity of DCR
PrP and the trans-rescuing activity of WT PrP can both be
detected in a non-CNS derived, transformed cell type (HEK293
cells).
Discussion
Expression of DCR PrP sensitizes several different cell lines to
certain cationic antibiotics, including Zeocin, G418 and hygro-
micin, an effect that can be quantitated by the DBCA [16]. This
drug-sensitizing effect is directly correlated with the ability of DCR
PrP, and related mutant PrPs, to induce ion channels in the cell
membrane, and with the neurotoxicity of these mutants in
transgenic mice [11]. Importantly, co-expression of WT PrP
suppresses both the drug hypersensitivity and ion channel activity
of DCR PrP in cultured cells [15], analogous to the ability of WT
PrP to reverse the neurodegenerative phenotype of Tg(DCR) mice
[11]. Thus, the DBCA measures a physiologically relevant,
functional activity of PrP.
Here, we have used a novel format of the DBCA to further
characterize the drug-hypersensitizing effect of DCR PrP and the
rescuing activity of WT PrP in differentiated NSCs. We found that
DCR induces hypersensitivity to drugs in a cell-autonomous
fashion (i.e., in cis), and that this effect is suppressed by WT PrP
supplied from adjacent cells (i.e., in trans). These results suggest that
two topologically different states of PrP are responsible for the
cytotoxic and cytoprotective activities of the protein, with the first
acting on the same cell to which PrP is attached, and the second
directed toward neighboring cells.
The toxicity DCR PrP is cell-autonomous
By co-culturing NSCs that express DCR PrP with those that
lack PrP expression, we were able to assess whether the toxic
activity of DCR PrP is cell-autonomous. We found that, while
NSCs expressing DCR PrP were killed by Zeocin, adjacent cells
lacking PrP were not. These results suggest that DCR PrP acts cell-
autonomously to confer Zeocin sensitivity. Our results argue
against the possibility that soluble forms of DCR PrP, or other
toxic molecules, are released from cells and act on adjacent cells,
or that membrane-bound DCR PrP exerts toxic effects on closely
opposed cells. In our experimental system, NSCs with and without
PrP were co-cultured and then differentiated into the three major
cell types (neurons, astrocytes, and oligodenrocytes), so that DCR
PrP-expressing cells were closely interdigitated with Prn-p
0/0 cells.
However, our results do not rule out possible trans-effects of DCR
PrP, if these were significantly less potent than the cis-effects.
Our data are consistent with several previous studies in
transgenic mice indirectly suggesting that DCR PrP, as well as
other PrP deletion mutants, exert their toxicity in cis. In addition to
DCR PrP, several other PrP mutants carrying deletions spanning
the central region, including D32–121, D32–134 and D94–134,
Figure 9. WT PrP rescuing activity can be exerted in trans. Mixed cultures of GFP-negative or GFP-positive NSCs from of Tga or DCR mice were
treated and analyzed as described in Figure 8. The bar graph shows the number of TUNEL-positive cells, expressed as a percentage of the number of
DAPI-stained cells, as determined in 5 fields for each sample group. Bars show means 6 SEM (n=4 independent experiments). The number of TUNEL-
positive DCR cells, either GFP-positive or GFP-negative, was significantly reduced when these cells were co-cultured with WT PrP-expressing Tga cells
(** p,0.01).
doi:10.1371/journal.pone.0033472.g009
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mice, characterized by loss of cerebellar granular neurons,
astrogliosis, and white matter vacuolization [20,21]. The expres-
sion pattern of these mutant PrPs in the brain is similar to that of
endogenous PrP
C, with the exception that cerebellar Purkinje cells
do not express the protein because the transgenic vector lacks a
Purkinje cell-specific enhancer element. Purkinje cells, in contrast
to granule neurons, do not degenerate in these Tg lines [11,20,21].
This observation indicates that, as is the case for DCR PrP, the
toxicity of the other PrP deletion mutants is also cell autonomous,
and is not transferred to neighboring cells.
WT PrP displays a trans-rescuing effect, which may reflect
a physiological activity of the protein
To assess the trans-rescuing activity of WT PrP, we co-cultured
NSCs expressing DCR PrP with NSCs expressing WT PrP. We
observed that WT PrP acted in trans to suppress the Zeocin
hypersensitivity of nearby cells expressing DCR PrP. Interestingly,
this rescuing effect was only partial, since Zeocin sensitivity was
not reduced to the level observed when the Tga20 (WT PrP) and
DCR PrP transgenes were expressed in the same cell. One possible
explanation for this difference is that WT PrP exerts its rescuing
activity both in cis and in trans, with the first effect being stronger
than the second effect. An alternative possibility is that the trans-
rescuing effect exerted by WT PrP requires physical contact
between DCR PrP and Tga20 NSCs. In this case, the absence of
complete rescue could indicate that a small percentage of DCR
cells are not sufficiently close to Tga NSCs in the mixed culture.
The trans-rescuing effect of WT PrP observed here is consistent
with several previous observations. For example, a trans-rescuing
effect of WT PrP has also been observed in Tg(F35) mice which
express D32–134 PrP. Expression of a soluble form of PrP lacking
the GPI anchor, or expression of WT PrP restricted to astrocytes,
counteracted neuronal loss and white matter pathology, and
prolonged survival of Tg(F35) mice [22]. Similar results were
obtained in Tg mice expressing Doppel (Dpl), a PrP paralog that is
structurally homologous to D32–134 PrP and that induces a
neurodegenerative phenotype when ectopically expressed in the
brain [23]. In this case, degeneration of Purkinje cells expressing
Dpl was rescued by WT PrP expression in surrounding neurons and
Figure 10. Cis toxicity of DCR and trans rescuing activity of WT PrP are detectable in HEK293 cells. (A) Equivalent amounts of total
protein from lysates of HEK293 cells stably transfected with the empty vector (Vec), or with vectors encoding for WT or DCR PrPs, were analyzed by
Western bloting using 6D11 antibody to detect PrP. A homogenous population of DCR cells stably expressing GFP (GFP+) was obtained by lentiviral
transduction and FACS sorting. Other cells were not transduced with virus (GFP2)( B) GFP+ DCR cells were mixed with GFP2 cells expressing Vector,
WT or DCR PrP. Co-cultures were treated for 48 hrs with Zeocin (500 mg/ml), and imaged by detecting GFP fluorescence (i.–iii.), or by phase contrast
(iv.–vi.). (C) The bar graph shows the total number of cells after Zeocin treatment, expressed as a percentage of the number of untreated cells, as
determined in 8 fields for each sample group. Bars show means 6 SEM (n=4 independent experiments). GFP+ DCR-expressing cells are significantly
more susceptible to the Zeocin than co-cultured Vector cells (p,0.001). Moreover, the number of surviving GFP+ DCR cells is significantly increased
when these cells are co-cultured with GFP2 cells expressing WT PrP, but not with GFP2 cells expressing DCR PrP (** p,0.01).
doi:10.1371/journal.pone.0033472.g010
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several PrP mutants and Dpl can be rescued in trans by WT PrP.
The trans-rescuing activity of WT PrP may reflect a physiologic
activity of the molecule. Several pieces of evidence indicate that
PrP
C can function in a trans-cellular fashion in a variety of
physiological contexts. For example, PrP
C can act as a cellular
adhesion molecule, participating in neuronal survival, neurite
outgrowth, and synaptic function [7,9,26]. Another recent study
found that several PrP knockout mouse strains exhibited a chronic
demyelinating polyneuropathy when PrP
C was depleted from
neurons but not Schwann cells [27]. Interestingly, this pathology
was rescued when neuronal expression of PrP
C was restored,
suggesting that axonal PrP
C exerts a role in long-term mainte-
nance of myelin by interacting in trans with receptors or other
molecules on the surface of Schwann cells. Taken together, these
data indicate that PrP
C acts in a trans-cellular fashion in a variety
of important physiological processes. Therefore, the trans-rescuing
effect of WT PrP toward DCR-expressing cells observed in this
study could directly reflect a biological activity of the molecule.
Further characterization of the molecular aspects of WT PrP
trans-rescuing activity, and the identification of PrP domains
involved in this phenomenon, will likely provide fundamental
insights into the normal function of the protein.
Models to explain the cell-autonomous toxicity of DCR
PrP and the trans-rescuing activity of WT PrP
In addition to its ability to hypersensitize cells to several cationic
antibiotics, DCR PrP induces spontaneous inward currents in cells
that can be recorded by patch-clamping techniques [13]. There is
a close correlation between the current-inducing activity of
different PrP mutants and their drug-sensitizing activity, suggest-
ing that the two processes are mechanistically related, perhaps
because the cationic antibiotics pass through the PrP-related
channels. Characterization of the biophysical properties of the
DCR-induced currents indicates that they are produced by
relatively non-selective, cation-permeable channels or pores in
the cell membrane. DCR PrP-induced currents have been
observed in cells of both neuronal and non-neuronal origin from
a variety of species, ranging from insects to mammals. Therefore,
we previously hypothesized that DCR PrP regulates the activity of
an endogenous channel that is extremely well conserved and
widely expressed, or more likely, that the DCR PrP molecule itself
forms channels independent of other cellular proteins [13]. Both
possibilities are consistent with the data presented here, which
show that DCR-induced hypersensitivity to antibiotics is exerted in
a cell autonomous fashion, as would be expected for a protein that
either forms or modulates a channel in the cell membrane.
Recent studies have demonstrated that the N-terminal polybasic
domain (residues 23–31) is essential for the neurotoxicity, ion
channel activity, and drug-sensitizing capability of DCR PrP and
other N-terminally deleted PrP mutants [14,28]. This region has
also been shown to function as a protein transduction domain
capable of ferrying polypeptides across the plasma membrane
[29,30]. We hypothesize that residues 23–31 contribute to the cis-
activity of DCR PrP by allowing the polypeptide to insert into the
plasma membrane and form a pore (Figure 11A). In this scenario,
our data would imply the existence of a molecular or structural
constraint which prevents the PrP polypeptide from penetrating
Figure 11. Models for DCR PrP cis-toxicity and WT PrP trans-rescue. (A) Data from previous reports suggest that DCR PrP forms a channel or
pore in the plasma membrane, which allows cationic molecules (illustrated as yellow balls) such as the antibiotics used in the DBCA, to enter the cell.
(B) WT PrP on the surface of one cell exerts its protective effect in trans by silencing the channel on neighboring cells. A similar effect could be
produced by PrP molecules released into the medium or physically transferred from neighboring cells (not shown). The N-terminal polybasic domain
(residues 23–31, indicated in green) plays an important role in both the cis-toxicity of DCR PrP and the trans-rescuing effect of WT PrP.
doi:10.1371/journal.pone.0033472.g011
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effect in trans.
What is the mechanism for the trans-rescuing effect of WT PrP?
We have previously shown that DCR-dependent currents are
silenced by co-expression of WT PrP in the same cell [13]. One
possible explanation for this phenomenon is that WT PrP closes
the pore formed by DCR PrP, perhaps by physically interacting
with the mutant protein (Figure 11B). The data presented here
suggest that this function can be performed by WT PrP supplied
from an adjacent cell, either attached to the membrane (Fig. 11B),
or in a soluble form (not shown). It is known that PrP
C is
spontaneously released from cells by the action of endogenous
phospholipases, or by proteases that generate N-terminal frag-
ments [31,32,33]. In addition, intercellular transfer of GPI-
anchored PrP
C has been previously reported [34]. Interestingly,
we have shown that deletion of residues 23–31 greatly diminishes
the rescuing activity of WT PrP both in cell culture assays and
transgenic mice [28,35]. Therefore, in addition to playing a role in
the toxicity of DCR and other mutant forms of PrP, residues 23–
31 are also important for the neuroprotective activity of WT PrP.
Does prion toxicity involve a cell-autonomous activity of
PrP
C?
Several lines of evidence suggest that prion-induced neurode-
generation is directly dependent on the presence of PrP
C on the
neuronal surface [5,36]. For example, genetic deletion of neuronal
PrP
C in infected mice reverses some aspects of neuropathology and
prolongs survival, despite the continued presence of PrP
Sc [5,6].
Moreover, the absence of the glycolipid membrane anchor on
PrP
C, which results in secretion of the protein into the extracellular
space, causes dramatic changes in the characteristics of scrapie-
induced illness in mice [37]. Collectively, these observations
indicate that a normal, cell-autonomous activity of PrP
C mediates
PrP
Sc toxicity. This conclusion underlines an interesting parallel
between the cis-toxicity of DCR PrP and the neurotoxicity of
PrP
Sc. What is the explanation for this correlation? In one possible
scenario, binding of PrP
Sc to neuronal PrP
C could force the latter
to insert its N-terminus into the lipid bilayer and produce a DCR-
like channel, resulting in the generation of abnormal ionic currents
at the plasma membrane, and subsequent neurotoxicity [8].
Further studies will be necessary to determine whether abnormal,
PrP-related channel activity occurs in cells infected with prions.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Boston University Institutional
Animal Care and Use Committee (Permit Number: AN-14997).
Mice
Generation of Tga20
+/+/Prn-p
0/0 (Tga) and Tg(DCR)/Prn-p
0/0
(DCR) mice has been described previously. Tg(ACTB-EGFP/Prn-
p
0/0) mice were obtained by crossing C57BL/6-Tg(ACTB-EGFP)
mice (The Jackson Laboratory, Bar Harbor, Maine) twice with
Prn-p
0/0 mice on the C56BL6 background (EMMA, Munich,
Germany). In order to obtain NSCs of the different genotypes,
either green or black, Tg(DCR) mice expressing one copy of the
Tga20 transgene on the Prn-p
0/0 background [DCR
+/2/Tga20
+/2/
Prn-p
0/0] were mated to Tg(ACTB-EGFP
+/2/Prn-p
0/0) mice. E13.5
mouse embryos were genotyped by PCR analysis of limb DNA.
DNA was prepared using the Puregene DNA Isolation Kit (Gentra
Systems, Minneapolis, MN).
NSCs
Neural stem cells were obtained and cultured following a
procedure described previously [19], with minor modifications.
Brains dissected from E13.5 mouse embryos were triturated in
5 ml of NeuroCult NSC basal medium containing NeuroCult
NSC proliferation supplement (StemCell Technologies,Vancou-
ver, BC) along with 20 ng/ml EGF. Once formed, neurospheres
were differentiated by pipetting a 0.1–1 ml suspension (containing
approximately 30–40 mature neurospheres) into each well of an 8-
well chamber slide (Ibidi GmbH, Mu ¨nchen, Germany) containing
NeuroCult NSC basal medium with NeuroCult NSC differenti-
ation supplement (StemCell Technologies) along with 10 mg/ml
retinoic acid.
The DBCA was performed as described previously [16], with
minor modifications. Briefly, NSCs differentiated for 10 days were
treated with 500 mg/ml of Zeocin for 24 hrs, and stained by
TUNEL or with DAPI (see below) to assess cell death.
Western blots
Ten-percent (w/v) homogenates of mouse brain were prepared
using a glass/Teflon apparatus (10 strokes at 1,000 rpm) in ice-
cold Triton-DOC buffer (0.5% Triton-X-100, 0.5% sodium
deoxycholate, 150 mM NaCl, 50 mM Tris-HCl, pH 7.5), plus
protease inhibitors. The same buffer was also used to lyse NSCs.
Brain or cell lysates were centrifuged at 900 xg for 10 min to
remove debris prior to analysis by SDS-PAGE. In some cases,
proteins were enzymatically deglycosylated with PNGase F
according to the manufacturer’s directions (New England Biolabs,
Beverly, MA). Samples were then diluted 1:1 in 26Laemli sample
buffer (2% SDS, 10% glycerol, 100 mM Tris-HCl pH 6.8,
0.002% bromophenol blue, 100 mM DTT), heated at 95uC for
10 min, then analyzed by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE). Proteins were electrophoretically
transferred to polyvinylidene fluoride (PVDF) membranes, and
membranes were blocked for 10 min in 5% (w/v) non-fat dry milk
in Tris-buffered saline containing 0.005% Tween 20. After
incubation with appropriate primary and secondary antibodies,
signals were revealed using enhanced chemiluminescence (Amer-
sham Biosciences, Uppsala, Sweden), and visualized by a Biorad
XRS Chemidoc image scanner (Biorad, Hercules, CA).
Antibodies
Monoclonal anti-PrP antibody 6D11 (provided by Richard
Kascsak, Institute for Basic Research in Developmental Disabil-
ities, Staten Island, NY, USA), rabbit anti-glial fibrillary acidic
protein (GFAP) (Dako, Carpinteria, CA), anti-nestin (Clone Rat
401, StemCell Technologies) and anti-MAP-2 were all diluted
1:2,000 for Western blot and 1:1,000 for immunofluorescence.
Immunofluorescence staining
NSCs were differentiated in 8-well laminin-coated chamber
slides for 7–10 days. Cells were fixed with 4% paraformaldehyde
in PBS for 20 min, permeabilized with 0.5% Triton-X-100 in PBS
for 10 min, treated with blocking buffer (PBS+ 2% goat serum) for
30 min, then stained with appropriate primary and secondary
antibodies (1:1,000) in blocking buffer for 1 h. Nuclei were
counterstained with 1 mg/ml DAPI (Sigma Aldrich) for 5 min. For
terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL), cells plated on glass coverslips were fixed with 4%
paraformaldehyde for 20 min, rinsed twice with PBS, permeabi-
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using a TMR Red In Situ Cell Death Detection Kit, according to
manufacturers’ directions (Roche Applied Science, Indianapolis,
IN). Cell nuclei were counterstained with DAPI. Glass slides were
mounted with Gel/Mount (Biomeda, Foster City, CA) and imaged
on a Nikon TE2000E2 inverted fluorescence microscope equipped
with a CCD camera. Images were processed using MetaMorph
software (Molecular Devices, Sunnyvale, CA). The number of
TUNEL-positive cells, expressed as a percentage of DAPI-positive
cells, was determined in at least five fields for each sample group.
Time-lapse microscopy
Images were collected and analyzed with a Cell-R imaging
station (Olympus, Japan) coupled to an inverted microscope (IX
81, Olympus) equipped with an incubator to maintain constant
temperature (37uC) and CO2 (5%) values. Phase contrast and
fluorescence (GFP) images were acquired with a high-resolution
camera (ORCA, Hamamatsu, Japan) at 206 magnification.
Fluorescence images were acquired using an excitation filter of
450–480 nm, a dichroic mirror of 500 nm, and an emission filter
of 515 nm (Olympus). Five different frames, randomly sampled,
were analyzed. Images were acquired at 10 min intervals for a
total of 72 hours.
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